Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient's follow up?

Conclusion:
The relapse risk in Tunisian patients is higher in young women and patients with HER2+ and TN tumors. A long and close follow up is recommended for patients with HR and HER2. Conversely, we suggest that follow up in patients with TN could be spaced after 4 years (ARR being <1.5% after this period).

Source: Therapeutic Advances in Medical Oncology - April 15, 2015 Category: Cancer & Oncology Authors: Mejri, N., Boussen, H., Labidi, S., Benna, F., Afrit, M., Rahal, K. Tags: Original Research Source Type: research